Clinical efficacy and safety of anti-PD-1/PD-L1 treatments in non-small cell lung cancer (NSCLC)
Volume 47, Issue 1, December 2019, Page 4194-4201 .
Source: Artificial Cells, Blood Substitutes, and Biotechnology - Category: Biotechnology Authors: Tian Zeng Qin Qin Zhiheng Bian Jianjun Li Source Type: research
More News: Biotechnology | Cancer | Cancer & Oncology | Lung Cancer | Lung Transplant | Non-Small Cell Lung Cancer